New Mexico officials have committed a suite of financial incentives to the project, including job training grants and tax credits. The state anticipates the facility will generate over 200 permanent jobs and contribute $1.5 billion to the regional economy over the next decade. To manage the complex engineering and regulatory requirements, Eden has tapped Kiewit Nuclear Solutions to lead construction, while Sargent & Lundy continues its long-standing role in architectural and licensing support.
Eden Radioisotopes Secures State Backing for $1.4 Billion New Mexico Plant
With $1.4 billion in planned investment and a new partnership with Kiewit Nuclear Solutions, Eden Radioisotopes is moving to establish the first purpose-built medical isotope facility in the United States. The Lea County project aims to secure a domestic supply chain for critical diagnostic and cancer-treatment materials by 2030.
Currently, U.S. hospitals rely on aging international reactors for isotopes that often decay too rapidly for long-term stockpiling. Eden’s facility, rooted in research from Sandia National Laboratories, seeks to eliminate this dependency. The company filed its formal construction permit with the U.S. Nuclear Regulatory Commission in May, with a final decision expected by mid-2027. If approved, the site will represent a major shift in how the country sources materials essential for daily medical imaging and oncological care.
Comments (0)
No comments yet. Be the first!